Table 3 Hazard ratios, and 95% confidence intervals.

From: The potential impact of systemic anti-inflammatory therapies in psoriasis on major adverse cardiovascular events: a Korean nationwide cohort study

 

Biologic

Methotrexate

Cyclosporine

Mixed conventional systemic

Phototherapy

Mild disease

HRa (95% CI)

0.87 (0.55–1.36)

1.14 (0.84–1.55)

2.11 (1.64–2.71)

2.57 (2.05–3.22)

1.02 (0.98–1.06)

Reference

P valueb

P = .528

P = .394

P < .001

P < .001

P = .357

 
  1. CI, confidence interval; HR, hazard ratio; MACE, major adverse cardiovascular events.
  2. aAdjusted for age, sex, and comorbidities.
  3. bStatistically significant at the 5% level.
Back to article page